Denali Therapeutics Inc. Operating Leases, Rent Expense, Sublease Rentals
Denali Therapeutics Inc. (DNLI) reported Operating Leases, Rent Expense, Sublease Rentals of $900.00 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseSubleaseRentals1 · last filed 2021-02-26
- Denali Therapeutics Inc. operating leases, rent expense, sublease rentals for the quarter ending 2019-09-30 was $900.00K.
- Denali Therapeutics Inc. operating leases, rent expense, sublease rentals for the quarter ending 2019-06-30 was $800.00K.
- Denali Therapeutics Inc. operating leases, rent expense, sublease rentals for the quarter ending 2018-12-31 was $0.00.
- Denali Therapeutics Inc. operating leases, rent expense, sublease rentals for the quarter ending 2018-09-30 was $0.00.
- Denali Therapeutics Inc. operating leases, rent expense, sublease rentals for fiscal 2018 was $0.00.
- Denali Therapeutics Inc. operating leases, rent expense, sublease rentals for fiscal 2017 was $0.00.
| Period end | Operating Leases, Rent Expense, Sublease Rentals 3 month | Operating Leases, Rent Expense, Sublease Rentals 6 month | Operating Leases, Rent Expense, Sublease Rentals 9 month | Operating Leases, Rent Expense, Sublease Rentals 12 month |
|---|---|---|---|---|
| 2019-09-30 | $900.00K 10-Q · filed 2019-11-06 | $1.70M derived: sum of 2 quarters · filed 2019-11-06 | $1.70M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $800.00K 10-Q · filed 2019-08-06 | $800.00K 10-Q · filed 2019-08-06 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $0.00 derived: sum of 3 quarters · filed 2021-02-26 | $0.00 10-K · filed 2021-02-26 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | ||
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |